A detailed history of Ubs Group Ag transactions in Davita Inc. stock. As of the latest transaction made, Ubs Group Ag holds 148,173 shares of DVA stock, worth $23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
148,173
Previous 114,178 29.77%
Holding current value
$23 Million
Previous $15.8 Million 53.52%
% of portfolio
0.01%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$133.98 - $165.19 $4.55 Million - $5.62 Million
33,995 Added 29.77%
148,173 $24.3 Million
Q2 2024

Aug 13, 2024

SELL
$126.11 - $147.14 $1.23 Million - $1.44 Million
-9,779 Reduced 7.89%
114,178 $15.8 Million
Q1 2024

May 13, 2024

SELL
$103.89 - $139.21 $387,509 - $519,253
-3,730 Reduced 2.92%
123,957 $17.1 Million
Q4 2023

Feb 09, 2024

BUY
$73.2 - $108.8 $1.12 Million - $1.66 Million
15,246 Added 13.56%
127,687 $13.4 Million
Q3 2023

Nov 09, 2023

SELL
$94.53 - $112.68 $51.2 Million - $61 Million
-541,137 Reduced 82.8%
112,441 $10.6 Million
Q2 2023

Aug 11, 2023

BUY
$81.58 - $100.93 $50.1 Million - $61.9 Million
613,772 Added 1541.91%
653,578 $65.7 Million
Q1 2023

May 12, 2023

BUY
$74.68 - $85.82 $169,598 - $194,897
2,271 Added 6.05%
39,806 $3.23 Million
Q4 2022

Feb 08, 2023

SELL
$65.42 - $99.31 $171,007 - $259,596
-2,614 Reduced 6.51%
37,535 $2.8 Million
Q3 2022

Nov 10, 2022

BUY
$80.24 - $95.27 $1.76 Million - $2.09 Million
21,943 Added 120.53%
40,149 $3.32 Million
Q2 2022

Aug 10, 2022

SELL
$76.05 - $123.38 $24,564 - $39,851
-323 Reduced 1.74%
18,206 $1.46 Million
Q1 2022

May 16, 2022

SELL
$108.37 - $120.0 $218,907 - $242,400
-2,020 Reduced 9.83%
18,529 $2.1 Million
Q4 2021

Feb 14, 2022

BUY
$94.5 - $116.95 $145,908 - $180,570
1,544 Added 8.12%
20,549 $2.34 Million
Q3 2021

Nov 15, 2021

SELL
$116.26 - $133.78 $13.7 Million - $15.8 Million
-117,803 Reduced 86.11%
19,005 $2.21 Million
Q2 2021

Aug 13, 2021

BUY
$105.44 - $127.98 $3.58 Million - $4.34 Million
33,930 Added 32.98%
136,808 $16.5 Million
Q1 2021

May 12, 2021

BUY
$99.98 - $123.89 $417,316 - $517,116
4,174 Added 4.23%
102,878 $11.1 Million
Q4 2020

Feb 11, 2021

BUY
$82.82 - $117.4 $458,822 - $650,396
5,540 Added 5.95%
98,704 $11.6 Million
Q3 2020

Nov 12, 2020

SELL
$79.57 - $91.84 $4.97 Million - $5.74 Million
-62,503 Reduced 40.15%
93,164 $7.98 Million
Q2 2020

Jul 31, 2020

BUY
$65.52 - $88.28 $4.56 Million - $6.14 Million
69,578 Added 80.82%
155,667 $12.3 Million
Q1 2020

May 01, 2020

BUY
$64.99 - $88.5 $2.84 Million - $3.86 Million
43,669 Added 102.94%
86,089 $6.55 Million
Q4 2019

Feb 14, 2020

BUY
$54.2 - $75.03 $1.31 Million - $1.81 Million
24,150 Added 132.18%
42,420 $3.18 Million
Q3 2019

Nov 14, 2019

SELL
$52.55 - $63.28 $2.8 Million - $3.37 Million
-53,227 Reduced 74.45%
18,270 $1.04 Million
Q2 2019

Aug 14, 2019

BUY
$43.42 - $57.79 $2.3 Million - $3.07 Million
53,039 Added 287.35%
71,497 $4.02 Million
Q1 2019

May 14, 2019

SELL
$49.95 - $59.21 $6.62 Million - $7.85 Million
-132,632 Reduced 87.78%
18,458 $1 Million
Q4 2018

Feb 14, 2019

SELL
$48.73 - $76.08 $16.6 Million - $25.9 Million
-340,482 Reduced 69.26%
151,090 $7.78 Million
Q3 2018

Nov 14, 2018

BUY
$66.51 - $74.55 $2.77 Million - $3.11 Million
41,651 Added 9.26%
491,572 $35.2 Million
Q2 2018

Aug 14, 2018

BUY
$62.77 - $73.47 $16.6 Million - $19.4 Million
264,654 Added 142.85%
449,921 $31.2 Million
Q1 2018

May 15, 2018

BUY
$65.0 - $80.03 $903,825 - $1.11 Million
13,905 Added 8.11%
185,267 $12.2 Million
Q4 2017

Feb 14, 2018

BUY
$53.89 - $72.36 $5.69 Million - $7.65 Million
105,666 Added 160.84%
171,362 $12.4 Million
Q3 2017

Nov 14, 2017

SELL
$56.13 - $64.78 $75,887 - $87,582
-1,352 Reduced 2.02%
65,696 $3.9 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-17,533 Reduced 20.73%
67,048 $4.34 Million
Q1 2017

Nov 14, 2017

BUY
N/A
84,581
84,581 $5.75 Million

Others Institutions Holding DVA

About DAVITA INC.


  • Ticker DVA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 91,300,000
  • Market Cap $14.2B
  • Description
  • DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...
More about DVA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.